Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Director departure Inv. presentation Quarterly results Appointed director
|
ARGOS THERAPEUTICS INC (ARGS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/25/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/25/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/25/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/25/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/02/2018 |
4
| Katz Richard D (Vice President and CFO) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Granted 22,629 shares
@ $0 |
|
03/30/2018 |
4
| Harrelson Lori R. (Vice President of Finance) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Granted 22,629 shares
@ $0 |
|
03/30/2018 |
4
| Nicolette Charles A. (CSO and Vice President of R&D) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Granted 27,150 shares
@ $0 |
|
03/30/2018 |
4
| Abbey Jeffrey D (CEO) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Granted 67,887 shares
@ $0 |
|
01/12/2018 |
4
| Harrelson Lori R. (Vice President of Finance) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Sold 64,329 shares
@ $0.1647, valued at
$10.6k
|
|
01/12/2018 |
4
| Nicolette Charles A. (CSO and Vice President of R&D) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Sold 100,250 shares
@ $0.1646, valued at
$16.5k
|
|
01/12/2018 |
4
| Abbey Jeffrey D (President, CEO) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Sold 124,987 shares
@ $0.1646, valued at
$20.6k
|
|
01/12/2018 |
4
| Katz Richard D (Vice President and CFO) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Sold 104,435 shares
@ $0.1647, valued at
$17.2k
|
|
01/05/2018 |
4
| Abbey Jeffrey D (President, CEO) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Sold 114,702 shares
@ $0.1632, valued at
$18.7k
|
|
01/05/2018 |
4
| Katz Richard D (Vice President and CFO) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Sold 101,228 shares
@ $0.1634, valued at
$16.5k
|
|
01/05/2018 |
4
| Nicolette Charles A. (CSO and Vice President of R&D) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Sold 92,001 shares
@ $0.1637, valued at
$15.1k
|
|
01/05/2018 |
4
| Harrelson Lori R. (Vice President of Finance) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Sold 59,072 shares
@ $0.1635, valued at
$9.7k
|
|
01/05/2018 |
4
| Abbey Jeffrey D (President, CEO) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Sold 114,702 shares
@ $0.1632, valued at
$18.7k
|
|
11/02/2017 |
4
| Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Disposed of 99,495 shares
@ $795.96, valued at
$79.2M
|
|
09/28/2017 |
4
| MORRISON RICHARD G (Director) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Granted 30,000 options to buy
@ $0.17, valued at
$5.1k
|
|
08/31/2017 |
4
| Harrelson Lori R. (Vice President of Finance) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Granted 320,683 shares
@ $0 |
|
08/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/31/2017 |
4
| Nicolette Charles A. (Chief Science Officer) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Granted 499,445 shares
@ $0 |
|
08/31/2017 |
4
| Abbey Jeffrey D (CEO) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Granted 622,685 shares
@ $0 |
|
06/23/2017 |
4
| Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC
Txns:
| Bought options to buy
@ $0.5, valued at
$0 |
|
01/23/2017 |
4
| Harrelson Lori R. (Vice President Finance) has filed a Form 4 on ARGOS THERAPEUTICS INC |
01/23/2017 |
4
| Winterbottom Joan (Chief Human Resources Officer) has filed a Form 4 on ARGOS THERAPEUTICS INC |
01/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/23/2017 |
4
| Abbey Jeffrey D (CEO) has filed a Form 4 on ARGOS THERAPEUTICS INC |
01/23/2017 |
4
| Nicolette Charles A. (Chief Science Officer) has filed a Form 4 on ARGOS THERAPEUTICS INC |
01/20/2017 |
4
| Krol Igor (Director) has filed a Form 4 on ARGOS THERAPEUTICS INC |
01/20/2017 |
4
| van Deventer Sander (Director) has filed a Form 4 on ARGOS THERAPEUTICS INC |
01/20/2017 |
4
| Birner Hubert (Director) has filed a Form 4 on ARGOS THERAPEUTICS INC |
01/20/2017 |
4
| Carey Robert (Director) has filed a Form 4 on ARGOS THERAPEUTICS INC |
|
|
|